![Maximising the effectiveness of therapeutic vaccines a step closer | UCL News - UCL – University College London Maximising the effectiveness of therapeutic vaccines a step closer | UCL News - UCL – University College London](https://www.ucl.ac.uk/news/sites/news/files/vaccine_2.jpg)
Maximising the effectiveness of therapeutic vaccines a step closer | UCL News - UCL – University College London
![WHO highlights role of screening and vaccination in reaching hepatitis B control targets - PHE Screening WHO highlights role of screening and vaccination in reaching hepatitis B control targets - PHE Screening](https://phescreening.blog.gov.uk/wp-content/uploads/sites/152/2020/10/Hep-B-leaflets-4.jpg)
WHO highlights role of screening and vaccination in reaching hepatitis B control targets - PHE Screening
![VAXELIS® Diphtheria, Tetanus, Pertussis (acellular, component), Hepatitis B (rDNA), Poliomyelitis (inactivated), and Haemophilus type b conjugate vaccine (adsorbed) - Sanofi Campus VAXELIS® Diphtheria, Tetanus, Pertussis (acellular, component), Hepatitis B (rDNA), Poliomyelitis (inactivated), and Haemophilus type b conjugate vaccine (adsorbed) - Sanofi Campus](https://www.campus.sanofi/dam/jcr:0c54500d-4d31-44eb-80bf-2e9a160f9824/Vaxelis-_2_.2023-07-17-15-30-18.webp)
VAXELIS® Diphtheria, Tetanus, Pertussis (acellular, component), Hepatitis B (rDNA), Poliomyelitis (inactivated), and Haemophilus type b conjugate vaccine (adsorbed) - Sanofi Campus
![Supermarket vouchers improve completion of Hep B vaccination with drug users | Imperial News | Imperial College London Supermarket vouchers improve completion of Hep B vaccination with drug users | Imperial News | Imperial College London](https://www.imperial.ac.uk/news/image/mainnews2012/21994.jpg)
Supermarket vouchers improve completion of Hep B vaccination with drug users | Imperial News | Imperial College London
PHE South West Screening and Immunisation Team Good Practice Guidance for the management of the NHS Hepatitis B Neonatal and In
![Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X19310448-ga1.jpg)